Axsome Therapeutics, Inc. (AXSM) — Net Income

Annual figures by fiscal year, from SEC filings.

2014: -$6.00M2015: -$12.21M2016: -$27.20M2017: -$28.94M2018: -$30.97M2019: -$68.35M2020: -$102.90M2021: -$130.40M2022: -$187.13M2023: -$239.24M2024: -$287.22M2025: -$183.17M-$183.17M
2014Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$183.17M+36.2%
2024-$287.22M-20.1%
2023-$239.24M-27.8%
2022-$187.13M-43.5%
2021-$130.40M-26.7%
2020-$102.90M-50.6%
2019-$68.35M-120.7%
2018-$30.97M-7.0%
2017-$28.94M-6.4%
2016-$27.20M-122.8%
2015-$12.21M-103.5%
2014-$6.00M